Patent ID: 7807158

Claim:
An anti-IL-13Rα1 antibody, comprising variable heavy chain amino acid sequences CDR1, CDR2, and CDR3, and variable light chain amino acid sequences CDR1, CDR2 and CDR3, wherein said variable heavy chain CDR1-3 sequences are selected from the group consisting of the variable heavy chain amino acid sequences CDR1-3 of SEQ ID NO: 1, 3, 5 and 9 and wherein said variable light chain CDR1-3 sequences are selected from the group consisting of the variable light chain amino acid sequence CDR1-3 of SEQ ID NO: 2, 4, 6 and 10; or wherein said variable heavy chain CDR1-3 sequences are selected from the variable heavy chain amino acid sequence CDR1-3 of SEQ ID NO:7 and wherein said variable light chain CDR1-3 sequences are selected from the variable light chain amino acid sequence CDR1-3 of SEQ ID NO:8.